Skip to content
Search

Latest Stories

New guidance for entry to independent prescribing courses to be applicable from 1st October

The General Pharmaceutical Council (GPhC) has announced that the new requirement for independent prescribing courses will be applicable from 1st of October 2022.

Pharmacists currently taking independent prescribing courses and those who apply before 1 October won’t be affected by the changes.


The new guidance was agreed at the council meeting on 8 September and went to the initial education and training Advisory Group on 22 September where it was well received, the GPhC said.

“The guidance is now being finalized to reflect the discussions at the Council meeting and the initial education and training advisory group and will be published in October.”

The new guidance is relevant for both course providers and applicants and gives some specific suggestions and examples of what we may expect. It will support consistency in the way education providers applied the new standards and will help individual pharmacists to understand the relevant experience they would need before enrolling on a course.

“From 1 October 2022 the accreditation and reaccreditation of independent prescribing courses will be to the revised standards. Any course provider wishing to apply the revised entry requirements before they are due for reaccreditation will be invited to go through a short desktop approval process. They will need to submit evidence to show they’ve made the necessary changes to meet the new standards, which will be rapidly reviewed by the GPhC, to ensure a quick turnaround.”

This will allow course providers to accept pharmacists in line with the new entry requirements for their next cohort and potentially allow the change to be implemented as early as autumn 2022.

The council said: “Course providers will need to continue to apply the previous entry requirements until they have been approved against the revised aspects the standards. We recommend therefore that pharmacists wanting to apply for independent prescribing courses should check in advance with their preferred course providers to find out when they expect to be ready to accept applicants using the new entry requirements in the new revised standards.”

Changes to the requirements for entry to accredited independent prescribing courses were agreed by the General Pharmaceutical Council in May 2022. According to new guidance pharmacists will no longer need to have two years of practice and relevant experience in a specific clinical or therapeutic area to enrol in an independent prescribing course.

Instead, applicants must now have relevant experience in a pharmacy setting and be able to recognise, understand and articulate the skills and attributes required by a prescriber. This experience and awareness will act as the basis of their prescribing practice whilst training. Applicants must also identify an area of clinical or therapeutic practice on which to base their learning.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less